Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vericel Corproation (VCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 837,955
  • Shares Outstanding, K 43,347
  • Annual Sales, $ 63,920 K
  • Annual Income, $ -17,290 K
  • 36-Month Beta 2.92
  • Price/Sales 8.97
  • Price/Cash Flow N/A
  • Price/Book 8.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.05
  • Low Estimate 0.04
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.10 +19.88%
on 01/29/19
20.02 -3.60%
on 02/19/19
+1.31 (+7.28%)
since 01/18/19
3-Month
14.00 +37.86%
on 12/24/18
20.02 -3.60%
on 02/19/19
+2.65 (+15.92%)
since 11/20/18
52-Week
6.80 +183.82%
on 02/22/18
20.02 -3.60%
on 02/19/19
+12.30 (+175.71%)
since 02/20/18

Most Recent Stories

More News
Vericel to Participate in Multiple Upcoming Investor Conferences

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced participation in multiple upcoming investor conferences.

VCEL : 19.39 (+0.31%)
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter...

VCEL : 19.39 (+0.31%)
Vericel to Present at the 21st Annual Needham Growth Conference

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest...

VCEL : 19.39 (+0.31%)
Bull or Bear: Your Investment Strategy for 2019

Whether you're a bull or a bear, it may be a good idea to go defensive about now.

SCS : 17.49 (+0.06%)
VCTR : 12.60 (+1.78%)
INTT : 7.72 (+1.58%)
MMI : 38.97 (-1.49%)
III : 4.16 (+0.24%)
TIVO : 11.57 (+2.48%)
BEAT : 75.22 (+0.49%)
BMA : 51.25 (-1.44%)
DIOD : 41.03 (+1.03%)
PGR : 72.34 (+0.74%)
CPSI : 32.87 (-0.78%)
VCEL : 19.39 (+0.31%)
BHC : 23.50 (-6.71%)
VNDA : 20.44 (+1.49%)
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research

Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the publication of outcomes data for 954 burn patients treated...

VCEL : 19.39 (+0.31%)
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise

Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise

AYX : 72.53 (+1.67%)
MITK : 10.95 (+0.64%)
MTLS : 19.00 (+1.23%)
VCEL : 19.39 (+0.31%)
4 Stocks With Recent Price Strength to Maximize Your Gains

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

AYX : 72.53 (+1.67%)
MITK : 10.95 (+0.64%)
MTLS : 19.00 (+1.23%)
VCEL : 19.39 (+0.31%)
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year?

Is (VCEL) Outperforming Other Medical Stocks This Year?

VCEL : 19.39 (+0.31%)
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath

Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.

AMED : 130.01 (-2.03%)
CROX : 28.11 (-1.37%)
ACMR : 11.49 (+15.25%)
ATTU : 19.97 (+0.40%)
VCEL : 19.39 (+0.31%)
4 Healthcare Stocks That Popped More Than 100% in 2018

Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.

AMED : 130.01 (-2.03%)
STAA : 37.00 (-0.16%)
VCEL : 19.39 (+0.31%)
DXCM : 146.01 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade VCEL with:

Business Summary

Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the...

See More

Key Turning Points

2nd Resistance Point 20.27
1st Resistance Point 19.80
Last Price 19.39
1st Support Level 19.08
2nd Support Level 18.83

See More

52-Week High 20.02
Last Price 19.39
Fibonacci 61.8% 14.97
Fibonacci 50% 13.41
Fibonacci 38.2% 11.85
52-Week Low 6.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar